Comparison
Teduglutid vs. Triptorelin
Two peptides side-by-side — identity, evidence base, legal status and known adverse events.
Identity
Category
Research other
Research other
CAS no.
197922-42-2
57773-63-4
Molecular weight
3752.13 g/mol
1311.45 g/mol
Half-life
no data
3 h
Sequence
no data
pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2Mechanism of action
Teduglutid
Teduglutide activates the GLP-2 receptor, promoting growth and regeneration of small-intestinal villi, increasing nutrient and fluid absorption and thereby reducing dependence on parenteral nutrition. The glycine substitution at position 2 makes it resistant to rapid breakdown by DPP-4.
Triptorelin
Triptorelin binds with high affinity to the GnRH receptor in the pituitary. After initial stimulation of LH and FSH secretion (flare phase, about 1-2 weeks), receptor desensitisation follows with consecutive gonadotropin suppression. This results in a reversible chemical castration: in men testosterone, in women oestrogen suppression to the postmenopausal range.
Evidence base
Highest evidence
Human RCT
Human RCT
Studies
2
4
of which in humans
2
4
Effects recorded
2
3
Open conflicts
0
0
Documented adverse events
2
3
Legal status
Full entries
Frequently asked questions
- What is the difference between Teduglutid and Triptorelin?
- Teduglutid is classified as "Research other", while Triptorelin is classified as "Research other". Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. Triptorelin: Synthetic decapeptide GnRH agonist with increased affinity over native gonadotropin-releasing hormone. FDA- and EMA-approved since the 1980s for prostate cancer, endometriosis and precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Teduglutid or Triptorelin?
- The highest available evidence level is "Human RCT" for Teduglutid and "Human RCT" for Triptorelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Teduglutid and Triptorelin in Germany and the United States?
- Germany: Teduglutid — Prescription, Triptorelin — Prescription. United States: Teduglutid — Prescription, Triptorelin — Prescription. These are factual summaries with source and review date on the individual pages.